Advertisement
ResearchIn-Press PreviewAngiogenesisOncology
Open Access |
10.1172/JCI190596
1Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China
2Department of Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, United States of America
4Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, Tianjin, China
5Department of Pathology, Tianjin First Center Hospital, Tianjin, China
6Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, United States of America
Find articles by Wu, A. in: PubMed | Google Scholar
1Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China
2Department of Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, United States of America
4Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, Tianjin, China
5Department of Pathology, Tianjin First Center Hospital, Tianjin, China
6Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, United States of America
Find articles by Hao, Y. in: PubMed | Google Scholar
1Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China
2Department of Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, United States of America
4Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, Tianjin, China
5Department of Pathology, Tianjin First Center Hospital, Tianjin, China
6Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, United States of America
Find articles by Yan, X. in: PubMed | Google Scholar
1Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China
2Department of Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, United States of America
4Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, Tianjin, China
5Department of Pathology, Tianjin First Center Hospital, Tianjin, China
6Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, United States of America
Find articles by Liu, J. in: PubMed | Google Scholar
1Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China
2Department of Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, United States of America
4Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, Tianjin, China
5Department of Pathology, Tianjin First Center Hospital, Tianjin, China
6Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, United States of America
Find articles by Wang, L. in: PubMed | Google Scholar
1Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China
2Department of Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, United States of America
4Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, Tianjin, China
5Department of Pathology, Tianjin First Center Hospital, Tianjin, China
6Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, United States of America
Find articles by Jin, Y. in: PubMed | Google Scholar
1Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China
2Department of Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, United States of America
4Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, Tianjin, China
5Department of Pathology, Tianjin First Center Hospital, Tianjin, China
6Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, United States of America
Find articles by Liu, W. in: PubMed | Google Scholar
1Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China
2Department of Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, United States of America
4Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, Tianjin, China
5Department of Pathology, Tianjin First Center Hospital, Tianjin, China
6Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, United States of America
Find articles by Chen, X. in: PubMed | Google Scholar
1Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China
2Department of Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, United States of America
4Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, Tianjin, China
5Department of Pathology, Tianjin First Center Hospital, Tianjin, China
6Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, United States of America
Find articles by Jiang, Y. in: PubMed | Google Scholar
1Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China
2Department of Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, United States of America
4Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, Tianjin, China
5Department of Pathology, Tianjin First Center Hospital, Tianjin, China
6Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, United States of America
Find articles by
Girard, L.
in:
PubMed
|
Google Scholar
|
1Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China
2Department of Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, United States of America
4Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, Tianjin, China
5Department of Pathology, Tianjin First Center Hospital, Tianjin, China
6Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, United States of America
Find articles by
Shang, Z.
in:
PubMed
|
Google Scholar
|
1Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China
2Department of Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, United States of America
4Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, Tianjin, China
5Department of Pathology, Tianjin First Center Hospital, Tianjin, China
6Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, United States of America
Find articles by Yan, J. in: PubMed | Google Scholar
1Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China
2Department of Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, United States of America
4Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, Tianjin, China
5Department of Pathology, Tianjin First Center Hospital, Tianjin, China
6Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, United States of America
Find articles by Zhang, Z. in: PubMed | Google Scholar
1Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China
2Department of Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, United States of America
4Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, Tianjin, China
5Department of Pathology, Tianjin First Center Hospital, Tianjin, China
6Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, United States of America
Find articles by Gong, W. in: PubMed | Google Scholar
1Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China
2Department of Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, United States of America
4Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, Tianjin, China
5Department of Pathology, Tianjin First Center Hospital, Tianjin, China
6Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, United States of America
Find articles by Niu, Y. in: PubMed | Google Scholar
1Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China
2Department of Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, United States of America
4Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, Tianjin, China
5Department of Pathology, Tianjin First Center Hospital, Tianjin, China
6Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, United States of America
Find articles by Drapkin, B. in: PubMed | Google Scholar
1Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China
2Department of Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, United States of America
4Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, Tianjin, China
5Department of Pathology, Tianjin First Center Hospital, Tianjin, China
6Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, United States of America
Find articles by
Minna, J.
in:
PubMed
|
Google Scholar
|
1Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China
2Department of Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, United States of America
4Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, Tianjin, China
5Department of Pathology, Tianjin First Center Hospital, Tianjin, China
6Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, United States of America
Find articles by Terada, L. in: PubMed | Google Scholar
1Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China
2Department of Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, United States of America
4Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, Tianjin, China
5Department of Pathology, Tianjin First Center Hospital, Tianjin, China
6Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, United States of America
Find articles by Ma, Z. in: PubMed | Google Scholar
1Zhejiang Key Laboratory of Medical Epigenetics, Jiande Hospital, Department, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China
2Department of Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
3Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, United States of America
4Tianjin Institute of Urology, The 2nd Hospital of Tianjin Medical University, Tianjin, China
5Department of Pathology, Tianjin First Center Hospital, Tianjin, China
6Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
7Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, United States of America
Find articles by Liu, Z. in: PubMed | Google Scholar
Published July 23, 2026 - More info
Human carcinomas often gain aggressive characteristics and escape cell-type specific treatment regimens through cryptic shifts in lineage states. However, the underlying mechanisms that govern lineage plasticity in carcinomas are undefined. Here in this study, we found that PAX5, a neural/lymphatic transcription factor, contributed to neuroendocrine (NE) lineage transition. PAX5 was highly expressed in aggressive human NE carcinoma cells and tissues but not in non-NE cancer cells and tissues. Deletion of Pax5 in Rb1fl/fl;Trp53fl/fl mice caused a reduction of tumor vessels, loss of NE morphologic features and decreased expression of ASCL1, NCAM, and SYP, whereas ectopic expression of PAX5 in CC10-rtTA;TetO-hEGFRex19del/T790M mice adenocarcinomas and in LNCAP prostate cancer xenografts induces an angiogenic microenvironment and NE morphology. Importantly, antiangiogenic drugs reduced NE features of Rb1fl/fl;Trp53fl/fl tumors and blocked PAX5-induced NE transformation. These studies demonstrate an essential role of angiogenic microenvironment in transition/maintenance of NE lineage, suggesting that targeting PAX5 and its downstream signaling may modulate lineage transitions responsible for treatment failure in both SCNCs and adenocarcinomas.